PSYCHIATRIC-MENTAL HEALTH NP · ANCC CERTIFICATION
PMHNP ANCC EXAM 2
A+
Psychiatric-Mental Health Nurse Practitioner Certification
2026/2027 Official Exam | Grade A | 100% Verified Solutions
Original high-yield examination aligned to the public ANCC PMHNP-BC test content outline. Application-, analysis-, and synthesis-level items
covering scientific foundations, psychopharmacology, assessment and risk, DSM-5-TR diagnosis, psychotherapy, and ethics/legal/cultural care.
A+ 6 100%
QUESTIONS VERIFIED EXAM DOMAINS COVERED RATIONALES INCLUDED
CATEGORIES
■ Section 1: Scientific Foundation & Neurobiology (Q1–8)
■ Section 2: Psychopharmacology (Q9–18)
■ Section 3: Assessment, Interviewing & Risk (Q19–27)
■ Section 4: Diagnosis (DSM-5-TR) & Differentials (Q28–36)
■ Section 5: Psychotherapy & Treatment Planning (Q37–43)
■ Section 6: Ethics, Legal Principles & Cultural Care (Q44–50)
Passing Score: 75% · 1 mark per question · Application / Analysis / Synthesis level
STUVIAACTUALEXAM
, SECTION: SCIENTIFIC FOUNDATION & NEUROBIOLOGY
Q1. A 34-year-old patient with major depressive disorder has failed two SSRIs. The PMHNP considers the monoamine hypothesis and the
role of BDNF. Reduced hippocampal BDNF is most closely associated with:
A. Enhanced neurogenesis and rapid antidepressant response
B. Impaired neuroplasticity and sustained depressive symptoms that may improve with effective antidepressant treatment
C. Primary dopaminergic hyperactivity in the nigrostriatal pathway
D. Exclusive GABA-A receptor upregulation without serotonergic involvement
Correct Answer: B
Rationale: Chronic stress and depression are linked to decreased BDNF and reduced hippocampal neurogenesis. Effective antidepressants and some
neuromodulation approaches can restore BDNF signaling and support recovery of plasticity.
Q2. A patient develops extrapyramidal symptoms after starting a first-generation antipsychotic. The pathway primarily implicated in these
movement side effects is the:
A. Mesocortical dopaminergic pathway
B. Tuberoinfundibular pathway only
C. Nigrostriatal dopaminergic pathway
D. Mesolimbic reward pathway exclusively
Correct Answer: C
Rationale: Blockade of D2 receptors in the nigrostriatal pathway produces Parkinsonian features, dystonia, and akathisia. The other pathways mediate different
clinical effects (negative symptoms, prolactin, reward).
Q3. During a discussion of the HPA axis in chronic PTSD, the PMHNP notes that many patients show:
A. Dysregulated cortisol patterns, often with enhanced negative feedback and lower basal cortisol in some chronic PTSD cohorts
B. Consistently elevated cortisol with no feedback abnormalities
C. Complete absence of CRF release from the hypothalamus
D. Primary adrenal hyperplasia as the sole finding
Correct Answer: A
Rationale: PTSD is associated with complex HPA-axis alterations; many studies show lower basal cortisol and increased glucocorticoid receptor sensitivity
rather than simple hypercortisolemia.
Q4. A patient asks how lithium is thought to stabilize mood. One evidence-supported mechanism involves:
A. Purely antagonistic action at 5-HT2A receptors with no intracellular effects
B. Irreversible MAO inhibition identical to phenelzine
C. Selective blockade of voltage-gated sodium channels only, identical to carbamazepine
D. Modulation of intracellular signaling, including inhibition of inositol monophosphatase and effects on GSK-3, contributing to neuroprotective and
mood-stabilizing actions
Correct Answer: D
Rationale: Lithium influences second-messenger systems (inositol depletion, GSK-3 inhibition) and has neurotrophic effects; these intracellular actions are
central to current models of its efficacy.
Q5. Neuroimaging in a first-episode psychosis patient shows enlarged ventricles and reduced gray-matter volume in frontotemporal regions.
These structural findings are most consistent with:
A. Neurodevelopmental and progressive changes frequently observed in schizophrenia-spectrum illness
B. A purely transient stress response with no illness correlation
C. Diagnostic proof of bipolar disorder without further assessment
D. Normal aging changes expected by age 25
Correct Answer: A
Rationale: Ventricular enlargement and cortical volume loss, particularly in frontal and temporal regions, are well-replicated structural correlates of
schizophrenia and related psychoses.
STUVIAACTUALEXAM | Page 2 of 12
PMHNP ANCC EXAM 2
A+
Psychiatric-Mental Health Nurse Practitioner Certification
2026/2027 Official Exam | Grade A | 100% Verified Solutions
Original high-yield examination aligned to the public ANCC PMHNP-BC test content outline. Application-, analysis-, and synthesis-level items
covering scientific foundations, psychopharmacology, assessment and risk, DSM-5-TR diagnosis, psychotherapy, and ethics/legal/cultural care.
A+ 6 100%
QUESTIONS VERIFIED EXAM DOMAINS COVERED RATIONALES INCLUDED
CATEGORIES
■ Section 1: Scientific Foundation & Neurobiology (Q1–8)
■ Section 2: Psychopharmacology (Q9–18)
■ Section 3: Assessment, Interviewing & Risk (Q19–27)
■ Section 4: Diagnosis (DSM-5-TR) & Differentials (Q28–36)
■ Section 5: Psychotherapy & Treatment Planning (Q37–43)
■ Section 6: Ethics, Legal Principles & Cultural Care (Q44–50)
Passing Score: 75% · 1 mark per question · Application / Analysis / Synthesis level
STUVIAACTUALEXAM
, SECTION: SCIENTIFIC FOUNDATION & NEUROBIOLOGY
Q1. A 34-year-old patient with major depressive disorder has failed two SSRIs. The PMHNP considers the monoamine hypothesis and the
role of BDNF. Reduced hippocampal BDNF is most closely associated with:
A. Enhanced neurogenesis and rapid antidepressant response
B. Impaired neuroplasticity and sustained depressive symptoms that may improve with effective antidepressant treatment
C. Primary dopaminergic hyperactivity in the nigrostriatal pathway
D. Exclusive GABA-A receptor upregulation without serotonergic involvement
Correct Answer: B
Rationale: Chronic stress and depression are linked to decreased BDNF and reduced hippocampal neurogenesis. Effective antidepressants and some
neuromodulation approaches can restore BDNF signaling and support recovery of plasticity.
Q2. A patient develops extrapyramidal symptoms after starting a first-generation antipsychotic. The pathway primarily implicated in these
movement side effects is the:
A. Mesocortical dopaminergic pathway
B. Tuberoinfundibular pathway only
C. Nigrostriatal dopaminergic pathway
D. Mesolimbic reward pathway exclusively
Correct Answer: C
Rationale: Blockade of D2 receptors in the nigrostriatal pathway produces Parkinsonian features, dystonia, and akathisia. The other pathways mediate different
clinical effects (negative symptoms, prolactin, reward).
Q3. During a discussion of the HPA axis in chronic PTSD, the PMHNP notes that many patients show:
A. Dysregulated cortisol patterns, often with enhanced negative feedback and lower basal cortisol in some chronic PTSD cohorts
B. Consistently elevated cortisol with no feedback abnormalities
C. Complete absence of CRF release from the hypothalamus
D. Primary adrenal hyperplasia as the sole finding
Correct Answer: A
Rationale: PTSD is associated with complex HPA-axis alterations; many studies show lower basal cortisol and increased glucocorticoid receptor sensitivity
rather than simple hypercortisolemia.
Q4. A patient asks how lithium is thought to stabilize mood. One evidence-supported mechanism involves:
A. Purely antagonistic action at 5-HT2A receptors with no intracellular effects
B. Irreversible MAO inhibition identical to phenelzine
C. Selective blockade of voltage-gated sodium channels only, identical to carbamazepine
D. Modulation of intracellular signaling, including inhibition of inositol monophosphatase and effects on GSK-3, contributing to neuroprotective and
mood-stabilizing actions
Correct Answer: D
Rationale: Lithium influences second-messenger systems (inositol depletion, GSK-3 inhibition) and has neurotrophic effects; these intracellular actions are
central to current models of its efficacy.
Q5. Neuroimaging in a first-episode psychosis patient shows enlarged ventricles and reduced gray-matter volume in frontotemporal regions.
These structural findings are most consistent with:
A. Neurodevelopmental and progressive changes frequently observed in schizophrenia-spectrum illness
B. A purely transient stress response with no illness correlation
C. Diagnostic proof of bipolar disorder without further assessment
D. Normal aging changes expected by age 25
Correct Answer: A
Rationale: Ventricular enlargement and cortical volume loss, particularly in frontal and temporal regions, are well-replicated structural correlates of
schizophrenia and related psychoses.
STUVIAACTUALEXAM | Page 2 of 12
